CDKN2A and type 2 diabetes mellitus: In addition, p16INK4a plays a role in T-lymphocytes, an immune cell type involved in type 2 diabetes [17] and atherosclerosis [13] development, by inhibiting their activation-induced proliferation [18] and by inducing apoptosis [19].